Inventor
AMENDT CHRISTIANE
DE25 patents
⚠️ This page may combine multiple inventors who share the name “AMENDT CHRISTIANE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK PATENT GMBH
11 patentsUS7691870B2Apr 6, 2010
Benzimidazole carboxamides as raf kinase inhibitors
MERCK PATENT GMBH30 citations92
US7589112B2Sep 15, 2009
Methylene urea derivatives
MERCK PATENT GMBH9 citations83
US7598274B2Oct 6, 2009
Pyrrole derivatives
MERCK PATENT GMBH7 citations73
US9051307B2Jun 9, 2015
Bipyridyl derivatives
MERCK PATENT GMBH2 citations63
US8912216B2Dec 16, 2014
Hetaryl-[1,8]naphthyridine derivatives
MERCK PATENT GMBH2 citations63
US7875614B2Jan 25, 2011
Phthalazinones
MERCK PATENT GMBH2 citations62
US7893082B2Feb 22, 2011
Substituted tetrahydroquinolines
MERCK PATENT GMBH2 citations61
US7915416B2Mar 29, 2011
Tetrahydroquinolines
MERCK PATENT GMBH1 citations51
US9382244B2Jul 5, 2016
7-azaindole-2,7-naphthyridine derivative for the treatment of tumours
MERCK PATENT GMBH1 citations46
US7691886B2Apr 6, 2010
Benzimidazole derivatives as raf kinase inhibitors
MERCK PATENT GMBH0 citations41
US7476683B2Jan 13, 2009
Glycinamide derivatives as raf-kinase inhibitors
MERCK PATENT GMBH0 citations41
HOELZEMANN GUENTER
3 patentsJONCZYK ALFRED
3 patentsSCHIEMANN KAI
2 patentsDORSCH DIETER
2 patentsUS8791113B2Jul 29, 2014
2,4-diaryl-substituted [1,8] naphthyridines as kinase inhibitors for use against cancer
DORSCH DIETER17 citations84
US9051318B2Jun 9, 2015
Pyrido [2, 3-B] pyrazine compounds and their therapeutical uses such as for inhibiting ATP consuming proteins and treating diseases associated therewith
DORSCH DIETER6 citations73